Chiesi’s Elfabrio receives NICE recommendation
The therapy has been developed for the treatment of Fabry disease among adult patients
Read More
Tag: Recommendation
Institute of Cancer Research embraces olaparib recommendation
Vital AstraZeneca therapy may transform lives of people with certain breast and prostate cancers
Read More
Novartis’ Beovu recommended by NICE
Patients set to benefit from new treatment for sight-threatening eye condition
Read More
NICE recommends Opdivo as post-surgery treatment
The therapy will be used for specific muscle invasive urothelial cancer patients
Read More
Hundreds of urothelial cancer patients to receive new treatment
NICE recommends avelumab as treatment for adults with locally advanced or metastatic urothelial cancer
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
